Azabicyclo and diazepine derivatives

A compound or a pharmaceutically acceptable salt thereof, wherein the compound is presented by formula (I):

• wherein
• Me=CH3;
• A=NR5;
• X=—OH, —O—Y—Z, —S—Y—Z, or —NR5—Y—Z;
• R1 and R2 are independently H, D, hydroxyl, alkoxy, nitrile, halogen atoms, C1-C20 straight, branched or cyclo alkyl groups optionally substituted with halogen atoms;
• or
• R1 and R2 are independently phenyl or benzyl groups being optionally substituted with one or more substituents selected from C1-C20 straight, branched or cyclo alkyl groups, halo alkyl groups, hydroxyl, alkoxy, nitrile, nitro, amino, amide, ester, sulfone, sulfoxide, sulfonamide, and halogen atoms;
• or
• R1 and R2 are independently a heterocyclic saturated, unsaturated or aromatic 5- or 6-member ring containing one or more heteroatoms selected from nitrogen, oxygen and sulfur and being optionally substituted with one or more substituents selected from C1-C20 straight, branched or cyclo alkyl, halo alkyl groups, hydroxyl, alkoxy, nitrile, nitro, amino, amide, ester, sulfone, sulfoxide or halogen atoms;
• R3 and R4 are independently hydrogen, C1-C10 straight or branched or cyclo alkyl or halo alkyl groups or
• R3 and R4 can combine to form 3- to 6-membered rings;
• R5═H, a C1-C20 straight or branched alkyl groups, or a C1-C10 straight or branched haloalkyl groups;
• Y is a bivalent radical having the following meaning:
• a) Straight or branched C1-C20 alkyl, being optionally substituted with one or more of the substituents selected from the group consisting of:
• halogen atoms and hydroxyl;
• b) —C(O)(C1-C10 alkyl)- or —C(O)(CH2)nC(O)O—(C1-C10 alkyl)- or —(C1-C10 alkyl)-;
• c)
• d)
• e)
• or
• f)
• wherein n is an integer from 0 to 20;
• R6 and R7 are independently H or C1-C10, straight or branched alkyl groups, C1-C10 straight or branched haloalkyl groups;
• or
• R6 and R7 can combine to form 3- to 6-membered rings;
• and
• Z is H, —OH, C1-6 alkoxy, —COOH, —NR8R9;
• R8 and R9 are independently C1-C20 alkyl, being optionally substituted with one or more substituents selected from hydroxyl, amino, ester, carboxylic acid, and halogen atoms;
• or
• R8 and R9 can combine to form 3- to 6-membered rings containing one or more heteroatoms which are selected from the group consisting of: